Latest News

The UK medicines regulator (MHRA) has approved EURneffy®, the country’s first needle-free adrenaline nasal spray for the emergency treatment of serious allergic reactions (anaphylaxis) in adults and children weighing 30kg or more.

This new option is expected to become available towards the end of 2025, giving people at risk of life-threatening allergies a new way to carry life-saving medication. 

For more information CLICK HERE

‹ Back Other News ›